Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ORCA Therapeutics
company
About
ORCA Therapeutics isdesigns and develops therapeutics for the treatment of cancer using Oncolytic Replication Competent Agents (ORCA).
- 1 - 10
Highlights
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- €5M
- Industries
- Biotechnology,Health Care,Life Science,Pharmaceutical
- Founded date
- Jan 1, 2005
- Number Of Employee
- 1 - 10
- Operating Status
- Active
ORCA Therapeutics is a biopharmaceutical company, designs and develops therapeutics for the treatment of cancer using Oncolytic Replication Competent Agents (ORCA). The ORCA agents/oncolytic viruses are derived from naturally occurring viruses and are engineered to selectively destroy cancer cells, while healthy cells are left unharmed.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€5M
ORCA Therapeutics has raised a total of
€5M
in funding over 2 rounds. Their latest funding was raised on
Nov 8, 2011 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 8, 2011 | Debt Financing | €5M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
ORCA Therapeutics is funded by 1 investors.
Agentschap NL
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Debt Financing |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
